Moreover, obvious correlations were observed between p62 overexpression and clinicopathological characteristics including lymph node metastasis (RR = 1.21, 95% CI: 1.06–1.37) and clinical stages (RR = 1.27, 95% CI: 1.12–1.45), which indicated general roles of p62 in cancer prognosis. The gene discussed is SQSTM1; the disease is metastatic malignant neoplasm in the lymph nodes.